Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
2009-9-24
pubmed:abstractText
Resolvins and lipoxins are lipid mediators generated from essential polyunsaturated fatty acids that are the first dual anti-inflammatory and pro-resolving signals identified in the resolution phase of inflammation. Here the authors investigated the potential of aspirin-triggered lipoxin (LX) A4 analog (ATLa), resolving (Rv) D1, and RvE1, in regulating angiogenesis in a murine model.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/16-(4-fluoro)phenoxylipoxin A4..., http://linkedlifedata.com/resource/pubmed/chemical/5S,12R,18R-trihydroxy-6Z,8E,10E,14Z..., http://linkedlifedata.com/resource/pubmed/chemical/Angiogenesis Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Cytokines, http://linkedlifedata.com/resource/pubmed/chemical/Docosahexaenoic Acids, http://linkedlifedata.com/resource/pubmed/chemical/Eicosapentaenoic Acid, http://linkedlifedata.com/resource/pubmed/chemical/Fpr1 protein, mouse, http://linkedlifedata.com/resource/pubmed/chemical/Lipoxins, http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Formyl Peptide, http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor A, http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor C, http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor..., http://linkedlifedata.com/resource/pubmed/chemical/resolvin D1, http://linkedlifedata.com/resource/pubmed/chemical/vascular endothelial growth factor..., http://linkedlifedata.com/resource/pubmed/chemical/vascular endothelial growth factor...
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1552-5783
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
50
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
4743-52
pubmed:dateRevised
2011-6-14
pubmed:meshHeading
pubmed-meshheading:19407006-Angiogenesis Inhibitors, pubmed-meshheading:19407006-Animals, pubmed-meshheading:19407006-Corneal Neovascularization, pubmed-meshheading:19407006-Cytokines, pubmed-meshheading:19407006-Disease Models, Animal, pubmed-meshheading:19407006-Docosahexaenoic Acids, pubmed-meshheading:19407006-Down-Regulation, pubmed-meshheading:19407006-Eicosapentaenoic Acid, pubmed-meshheading:19407006-Fluorescent Antibody Technique, Indirect, pubmed-meshheading:19407006-Lipoxins, pubmed-meshheading:19407006-Macrophages, pubmed-meshheading:19407006-Male, pubmed-meshheading:19407006-Mice, pubmed-meshheading:19407006-Mice, Inbred BALB C, pubmed-meshheading:19407006-Neutrophils, pubmed-meshheading:19407006-RNA, Messenger, pubmed-meshheading:19407006-Receptors, Formyl Peptide, pubmed-meshheading:19407006-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:19407006-Vascular Endothelial Growth Factor A, pubmed-meshheading:19407006-Vascular Endothelial Growth Factor C, pubmed-meshheading:19407006-Vascular Endothelial Growth Factor Receptor-2
pubmed:year
2009
pubmed:articleTitle
Anti-angiogenesis effect of the novel anti-inflammatory and pro-resolving lipid mediators.
pubmed:affiliation
Department of Ophthalmology, Schepens Eye Research Institute, Harvard Medical School, 20 Staniford Street, Boston, MA 02114, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural